NCT00006450View on ClinicalTrials.gov

Phenylbutyrate to Treat Children With Progressive or Recurrent Brain Tumors

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 30, 2000

Study Completion Date

July 31, 2002

Conditions
Brain Tumor
Interventions
DRUG

Phenylbutyrate

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00006450 - Phenylbutyrate to Treat Children With Progressive or Recurrent Brain Tumors | Biotech Hunter | Biotech Hunter